Since assuming office in January, Mr. Trump and his top aides, seasoned from their first stint in the White House, have ...

Excerpts from recent editorials in the United States and abroad: ___ Oct. 18 The Washington Post on Trump, Ukraine, and US leverage over Russia Tomahawk missiles were the talk of Washington this week.

Power, politics, and potholes — from Chamber cash to Jaguar crashes, Jacksonville keeps things interestingly uneven.

The U.S. Justice Department has announced an agreement with the University of Virginia to pause civil rights investigations.

In a long post on X Wednesday morning, Greene called out Johnson for claiming on a Republican Party conference call the day ...

President Donald Trump is planning to launch a new investigation into drug prices aimed at ensuring foreign countries pay as ...

While the threat of tariffs dies down for the pharma industry, President Donald Trump is reportedly weighing a new ...

Former Trump adviser lambastes president’s demand for $230 million from the DOJ: ‘This is taxpayer dollars’ - ‘Does he ...

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President ...

Just as pharmaceutical tariff uncertainty seemed to be easing in the U.S., the Trump administration is reportedly staging a ...

Healthcare may be evolving at lightning speed, but affordability remains the toughest pill to swallow. From breakthrough ...

ICON may be undervalued as market uncertainty fades. Learn more about ICLR stock's share buyback, profitability, and outlook ...